0 items USD 0.00Search
Your search for "global markets direct neuroblastoma pipeline review h1 2017" gave back 20778 results.
The global Chemotherapy Drugs for Neuroblastoma market size is projected to grow from US$ 120.3 million in 2022 to US$ 166.8 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Immunotherapy Drugs for Neuroblastoma market size is projected to grow from US$ 44 million in 2022 to US$ 61 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Market Analysis and Insights: Global Pediatric Neuroblastoma Treatment Market The global Pediatric Neuroblastoma Treatment market is projected to...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
The global Neuroblastoma Treatment market size was valued at US$ 434.3 million in 2023. With growing demand in downstream market, the Neuroblastoma...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Immunotherapy for Neuroblastoma market size is projected to grow from US$ 44 million in 2022 to US$ 61 million in 2029; it is expected to...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Chemotherapy for Neuroblastoma market size is projected to grow from US$ 120.3 million in 2022 to US$ 166.8 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Chemotherapy for Neuroblastoma market size was valued at USD 126.6 million in 2022 and is forecast to a readjusted size of USD 171.1...
Catalog:
GIR
July 2023
Price: USD 3,480.00
The global Immunotherapy for Neuroblastoma market size was valued at USD 46 million in 2022 and is forecast to a readjusted size of USD 63 million by...
Catalog:
GIR
July 2023
Price: USD 3,480.00
The global Chemotherapy for Neuroblastoma market size is expected to reach $ 171.1 million by 2029, rising at a market growth of 4.4% CAGR during the...
Catalog:
GIR
July 2023
Price: USD 4,480.00
The global Immunotherapy for Neuroblastoma market size is expected to reach $ 63 million by 2029, rising at a market growth of 4.4% CAGR during the...
Catalog:
GIR
July 2023
Price: USD 4,480.00
The global H1 Receptor Antagonist market size was valued at USD 35700 million in 2022 and is forecast to a readjusted size of USD 58730 million by...
Catalog:
GIR
August 2023
Price: USD 3,480.00
The global H1 Receptor Antagonist market size is projected to grow from US$ 33950 million in 2022 to US$ 58130 million in 2029; it is expected to...
Catalog:
LPI
July 2023
Price: USD 3,660.00
The global Cyclophosphamide market size was valued at USD 662.1 million in 2023 and is forecast to a readjusted size of USD 761.1 million by 2030...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The global H1 Receptor Antagonist market size is expected to reach $ 58730 million by 2029, rising at a market growth of 7.4% CAGR during the...
Catalog:
GIR
August 2023
Price: USD 4,480.00
Cyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As...
Catalog:
GIR
June 2023
Price: USD 3,480.00
